These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 38779783)
21. Efficacy of dual sublingual immunotherapy with Japanese cedar pollen and house dust mite allergens in patients with allergic rhinitis sensitized to multiple allergens. Fujii T; Kitamura Y; Kamimura S; Ishitani K; Takeda N Laryngoscope Investig Otolaryngol; 2022 Feb; 7(1):36-42. PubMed ID: 35155781 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of sublingual tablets of house dust mite allergen extracts: Results of a dose-ranging study in an environmental exposure chamber. Roux M; Devillier P; Yang WH; Montagut A; Abiteboul K; Viatte A; Zeldin RK J Allergy Clin Immunol; 2016 Aug; 138(2):451-458.e5. PubMed ID: 27289490 [TBL] [Abstract][Full Text] [Related]
23. New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases. Ferrando M; Bagnasco D; Passa-Lacqua G; Puggioni F; Varricchi G; Canonica GW Curr Pharm Biotechnol; 2017; 18(5):378-383. PubMed ID: 28413977 [TBL] [Abstract][Full Text] [Related]
24. A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study. Pfaar O; van Twuijver E; Boot JD; Opstelten DJ; Klimek L; van Ree R; Diamant Z; Kuna P; Panzner P Allergy; 2016 Jan; 71(1):99-107. PubMed ID: 26417901 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis. Okubo K; Masuyama K; Imai T; Okamiya K; Stage BS; Seitzberg D; Konno A J Allergy Clin Immunol; 2017 Jun; 139(6):1840-1848.e10. PubMed ID: 27864024 [TBL] [Abstract][Full Text] [Related]
27. The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): verification of nasal allergen challenge procedures in a study utilizing an investigational immunotherapy for cat allergy. Neighbour H; Soliman M; Steacy LM; Hickey P; Forbes B; Larché M; Ellis AK Clin Transl Allergy; 2018; 8():15. PubMed ID: 29682277 [TBL] [Abstract][Full Text] [Related]
28. Birch-induced allergic rhinitis: Results of exposure during nasal allergen challenge, environmental chamber, and pollen season. Gherasim A; Dietsch F; Beck M; Domis N; de Blay F World Allergy Organ J; 2023 Jul; 16(7):100801. PubMed ID: 37520615 [TBL] [Abstract][Full Text] [Related]
29. Allergen Stability and Immunological Reactivity during Co-dissolution and Incubation of House Dust Mite and Japanese Cedar Pollen SLIT-Tablets. Watanabe A; Yamamoto T; Matsuhara H; Matsui H; Nakazawa H; Lund K; Ohashi-Doi K Biol Pharm Bull; 2020 Oct; 43(10):1448-1450. PubMed ID: 32759600 [TBL] [Abstract][Full Text] [Related]
30. Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial. Scadding GW; Calderon MA; Shamji MH; Eifan AO; Penagos M; Dumitru F; Sever ML; Bahnson HT; Lawson K; Harris KM; Plough AG; Panza JL; Qin T; Lim N; Tchao NK; Togias A; Durham SR; JAMA; 2017 Feb; 317(6):615-625. PubMed ID: 28196255 [TBL] [Abstract][Full Text] [Related]
31. Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis. Jordakieva G; Kundi M; Lemell P; Zieglmayer R; Zieglmayer P; Godnic-Cvar J; Jensen-Jarolim E Sci Rep; 2017 May; 7(1):2555. PubMed ID: 28566688 [TBL] [Abstract][Full Text] [Related]
32. SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms. Mosbech H; Canonica GW; Backer V; de Blay F; Klimek L; Broge L; Ljørring C Ann Allergy Asthma Immunol; 2015 Feb; 114(2):134-40. PubMed ID: 25624131 [TBL] [Abstract][Full Text] [Related]
33. Correlation between sensitization to house dust mite major allergens, age, and symptoms in Japanese house dust mite allergic subjects. Hasegawa A; Utsumi D; Lund K; Okano M; Ohashi-Doi K; Okubo K Int Immunopharmacol; 2022 Jun; 107():108640. PubMed ID: 35217338 [TBL] [Abstract][Full Text] [Related]
34. The influence of house dust mite sublingual immunotherapy on the TSLP-OX40L signaling pathway in patients with allergic rhinitis. Meng Q; Liu X; Li P; He L; Xie J; Gao X; Wu X; Su F; Liang Y Int Forum Allergy Rhinol; 2016 Aug; 6(8):862-70. PubMed ID: 27012942 [TBL] [Abstract][Full Text] [Related]
35. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. Calderon MA; Casale TB; Nelson HS; Demoly P J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829 [TBL] [Abstract][Full Text] [Related]
36. Clinical efficacy of sublingual immunotherapy is associated with restoration of steady-state serum lipocalin 2 after SLIT: a pilot study. Roth-Walter F; Schmutz R; Mothes-Luksch N; Lemell P; Zieglmayer P; Zieglmayer R; Jensen-Jarolim E World Allergy Organ J; 2018; 11(1):21. PubMed ID: 30323863 [TBL] [Abstract][Full Text] [Related]
37. Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA Boelke G; Berger U; Bergmann KC; Bindslev-Jensen C; Bousquet J; Gildemeister J; Jutel M; Pfaar O; Sehlinger T; Zuberbier T Clin Transl Allergy; 2017; 7():33. PubMed ID: 28932387 [TBL] [Abstract][Full Text] [Related]
38. House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis. Okamoto Y; Fujieda S; Okano M; Yoshida Y; Kakudo S; Masuyama K Allergy; 2017 Mar; 72(3):435-443. PubMed ID: 27471838 [TBL] [Abstract][Full Text] [Related]
39. Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials? Pfaar O; Gerth van Wijk R Curr Treat Options Allergy; 2015; 2(1):1-9. PubMed ID: 25798370 [TBL] [Abstract][Full Text] [Related]
40. House dust mite sublingual immunotherapy in allergic rhinitis. Cho SW; Han DH; Kim JW; Kim DY; Rhee CS Immunotherapy; 2018 Jun; 10(7):567-578. PubMed ID: 29562802 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]